Anest. intenziv. Med. 2018;29(3):139-147

Management of convulsive status epilepticus in childrenReview Article

Š. Aulická1, P. Aulický2, K. Česká1, K. Španělová1, H. Ošlejšková1,*
1 Klinika dětské neurologie, Lékařská fakulta, Masarykova univerzita, Fakultní nemocnice Brno
2 Oddělení anesteziologie, resuscitace a intenzivní medicíny, Nemocnice Milosrdných bratří

Generalized convulsive status epilepticus (GCSE) is the most common neurological emergency in children. It is defined as a generalized convulsive seizure lasting longer than 5 minutes. The infantile and particularly neonatal period is the high-risk period for development of GCSE. The most common etiology is febrile status epilepticus. GCSE is divided into four stages: early (5-20 minutes), established (20-40 minutes), refractory (>40 minutes), and super-refractory (>24 hours). A generalized convulsive seizure lasting up to 5 minutes is called impending GCSE. This corresponds with the time in which adequate seizure termination treatment should be initiated.
Management of GCSE consists of basic life support (the ABC) and administration of antiepileptic drugs which will stop the seizure. Identification and treatment of the cause of the status is equally important. All antiepileptic drugs should be administrated intravenously. First line treatment of early-stage GCSE includes benzodiazepines (diazepam or clonazepam). Second line treatment of established GCSE includes one of the non-benzodiazepine antiepileptic drugs: phenytoin, valproate, levetiracetam, phenobarbital or lacosamide. In the case of failure of first-line and second-line treatment, i.e. in the refractory GCSE stage, IV anaesthetic drugs (thiopental, midazolam, or propofol) are commonly used. General anaesthesia should be maintained for 24 to 48 hours and the depth of the anaesthetic coma should be monitored by continuous EEG. When treatment with IV anaesthesia for more than 24 hours is unsuccessful in controlling the GCSE, the condition can be termed super-refractory GCSE. This condition is associated with high morbidity and mortality.

Keywords: convulsive status epilepticus; refractory status epilepticus; children

Received: February 12, 2018; Accepted: April 22, 2018; Published: June 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Aulická Š, Aulický P, Česká K, Španělová K, Ošlejšková H. Management of convulsive status epilepticus in children. Anest. intenziv. Med. 2018;29(3):139-147.
Download citation

References

  1. http://www.uptodate.com/contents/clinical-features-and-complications-of-status-epilepticus-in-children
  2. https://www.uptodate.com/contents/management-of-convulsive-status-epilepticus-in-children
  3. Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Currents. 2016;16:48. doi: 10.5698/1535-7597-16.1.48. Go to original source... Go to PubMed...
  4. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515-1523. Go to original source... Go to PubMed...
  5. Singh RK, Stephens S, Berl MM, et al. Prospective study of new-onset seizures presenting as status epilepticus in childhood. Neurology. 2010;74:636. Go to original source... Go to PubMed...
  6. https://emedicine.medscape.com/article/1164462-overview#a2
  7. Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51:671-675. doi: 10.1111/j.1528-1167.2009.02285. Go to original source... Go to PubMed...
  8. Meldrum BS. Pathophysiology. In: A Textbook of Epilepsy. Eds.: Laidlaw J, Richens A, Oxley J. Churchill Livingstone. 1988;203-235.
  9. Gaspard N, Foreman BP, Alvarez V, et al. Critical Care EEG Monitoring Research Consortium (CCEMRC). New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology. 2015;85:1604-1613. doi: 10.1212/WNL.0000000000001940. Go to original source... Go to PubMed...
  10. Khawaja AM, DeWolfe JL, Miller DW, et al. New-onset refractory status epilepticus (NORSE)--The potential role for immunotherapy. Epilepsy Behav. 2015;47:17. Go to original source... Go to PubMed...
  11. Howell KB, Katanyuwong K, Mackay MT, et al. Long-term follow-up of febrile infection-related epilepsy syndrome. Epilepsia. 2012;53:101. Go to original source... Go to PubMed...
  12. Fox K, Wells ME, Tennison M, et al. Febrile Infection-Related Epilepsy Syndrome (FIRES): A Literature Review and Case Study. Neurodiagn J. 2017;57:224-233. doi: 10.1080/21646821.2017.1355181. Go to original source... Go to PubMed...
  13. Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16:48-61. doi: 10.5698/1535-7597-16.1.48. PMCID: PMC4749120. Go to original source... Go to PubMed...
  14. www.epistop.cz
  15. https://www.uptodate.com/contents/juvenile-myoclonic-epilepsy
  16. Poddar K, Sharma R, Ng YT. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study. Pediatr Neurol. 2016;61:83-86. doi: 10.1016/j.pediatrneurol.2016.03.021. Go to original source... Go to PubMed...
  17. James L, Linda H, Paul K, et al. Guideline for the management of convulsive status epilepticus in infants and children. BC MEDICAL JOURNAL. 2011;53-56.
  18. https://lifeinthefastlane.com/ccc/propofol-infusion-syndrome/
  19. Nee-Hooi W, Priya N. Propofol infusion syndrome. Continuing Education in Anaesthesia, Critical Care & Pain. 2013;13:6. Go to original source...
  20. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:10. Go to original source... Go to PubMed...
  21. Aroor S, Shravan K, Mundkur S, et al. Super-refractory status epilepticus: A Therapeutic Challenge in Paediatrics. Journal of Clinical and Diagnostic Research. 2017;11:SR01-SR04. Go to original source... Go to PubMed...
  22. https://www.uptodate.com/contents/paraneoplastic-and-autoimmune-encephalitis#H2973236366
  23. Broomall E, Natale JE, Grimason M, et al. Pediatric Super-Refractory Status Epilepticus Treated With Allopregnanolone. Ann Neurol. 2014;76:911-915. Go to original source... Go to PubMed...
  24. Kenney-Jung DL, Vezzani A, Kahoud RJ, et al. Febrile infection-related epilepsy syndrome treated with anakinra. Ann Neurol. 2016;80:939-945. Go to original source... Go to PubMed...
  25. Raspall-Chaure M, Chin RF, Neville BG, et al. The epidemiology of convulsive status epilepticus in children: a critical review. Epilepsia. 2007;48:1652. Go to original source... Go to PubMed...
  26. Lambrechtsen FA, Buchhalter JR. Aborted and refractory status epilepticus in children: a comparative analysis. Epilepsia. 2008;49:615. Go to original source... Go to PubMed...
  27. https://www.uptodate.com/contents/treatment-of-neonatal-seizures
  28. Nicolai J, van Kranen-Mastenbroek VH, Wevers RA, et al. Folinic acid-responsive seizures initially responsive to pyridoxine. Pediatr Neurol. 2006;34:164. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.